The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study

BACKGROUND: The relative importance of predictive factors for advanced non-small cell lung cancer (NSCLC) patients on epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) treatment remains unclear. MATERIALS AND METHODS: We retrospectively enrolled advanced NSCLC patients with sin...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yen-Hsiang, Hung, Jen-Yu, Ko, How-Wen, Su, Po-Lan, Lai, Chun-Liang, Chang, Huang-Chih, Hsia, Te-Chun, Lin, Sheng-Hao, Wu, Kuan-Li, Yang, Cheng-Ta, Su, Wu-Chou, Chu, Yi-Chun, Wang, Chin-Chou, Liao, Wei-Yu, Lin, Yen-Ting, Lin, Ching-Hsiung, Lin, Meng-Chih, Hsu, Kuo-Hsuan, Tseng, Jeng-Sen, Yang, Tsung-Ying, Chen, Kun-Chieh, Lee, Mei-Hsuan, Yu, Sung-Liang, Ho, Chao-Chi, Chang, Gee-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Advances in Treatment of Lung Cancer Patients with Targetable Mutations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142001/
https://www.ncbi.nlm.nih.gov/pubmed/34093743
http://dx.doi.org/10.1177/17588359211018022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142001/
https://www.ncbi.nlm.nih.gov/pubmed/34093743
http://dx.doi.org/10.1177/17588359211018022

Ejemplares similares